| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |